Nanosonics Limited (ASX:NAN)

Australia flag Australia · Delayed Price · Currency is AUD
3.750
+0.070 (1.90%)
Apr 8, 2026, 10:09 AM AEST
Market Cap1.10B -25.4%
Revenue (ttm)207.26M +12.7%
Net Income20.56M +24.1%
EPS0.07 +24.7%
Shares Out299.89M
PE Ratio55.34
Forward PE57.77
Dividendn/a
Ex-Dividend Daten/a
Volume2,957,382
Average Volume1,012,147
Open3.760
Previous Close3.680
Day's Range3.740 - 3.790
52-Week Range3.210 - 5.080
Beta1.30
RSI53.32
Earnings DateFeb 23, 2026

About Nanosonics

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabi... [Read more]

Sector Healthcare
Founded 2000
Employees 470
Stock Exchange Australian Securities Exchange
Ticker Symbol NAN
Full Company Profile

Financial Performance

In fiscal year 2025, Nanosonics's revenue was 198.63 million, an increase of 16.83% compared to the previous year's 170.01 million. Earnings were 20.68 million, an increase of 59.39%.

Financial Statements